These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15858148)

  • 1. A novel method for creating artificial mutant samples for performance evaluation and quality control in clinical molecular genetics.
    Jarvis M; Iyer RK; Williams LO; Noll WW; Thomas K; Telatar M; Grody WW
    J Mol Diagn; 2005 May; 7(2):247-51. PubMed ID: 15858148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One multiplex control for 29 cystic fibrosis mutations.
    Lebo RV; Bixler M; Galehouse D
    Genet Test; 2007; 11(3):256-68. PubMed ID: 17949287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of CFTR gene mutation testing methods in 136 diagnostic laboratories: report of a large European external quality assessment.
    Dequeker E; Cassiman JJ
    Eur J Hum Genet; 1998; 6(2):165-75. PubMed ID: 9781062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technical validation of a TM Biosciences Luminex-based multiplex assay for detecting the American College of Medical Genetics recommended cystic fibrosis mutation panel.
    Strom CM; Janeszco R; Quan F; Wang SB; Buller A; McGinniss M; Sun W
    J Mol Diagn; 2006 Jul; 8(3):371-5. PubMed ID: 16825511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and use of a synthetic quality control material, included in the European external quality assessment scheme for cystic fibrosis.
    Berwouts S; Gordon JT; Rundell CA; Barton DE; Dequeker E
    Hum Mutat; 2008 Aug; 29(8):1063-70. PubMed ID: 18470946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The c.1364C>A (p.A455E) Mutation in the CFTR Pseudogene Results in an Incorrectly Assigned Carrier Status by a Commonly Used Screening Platform.
    Deeb KK; Metcalf JD; Sesock KM; Shen J; Wensel CA; Rippel LI; Smith M; Chapman MS; Zhang S
    J Mol Diagn; 2015 Jul; 17(4):360-5. PubMed ID: 25956447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of large rearrangements in the cystic fibrosis transmembrane conductance regulator gene by multiplex ligation-dependent probe amplification assay when sequencing fails to detect two disease-causing mutations.
    Svensson AM; Chou LS; Miller CE; Robles JA; Swensen JJ; Voelkerding KV; Mao R; Lyon E
    Genet Test Mol Biomarkers; 2010 Apr; 14(2):171-4. PubMed ID: 20059381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a screening test for 12 common mutations of the cystic fibrosis CFTR gene.
    Robertson NH; Weston SL; Kelly SJ; Duxbury NJ; Pearce SR; Elsmore P; Webb MB; Newton CR; Little S
    Eur Respir J; 1998 Aug; 12(2):477-82. PubMed ID: 9727805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved detection of cystic fibrosis mutations in infertility patients with DNA sequence analysis.
    Danziger KL; Black LD; Keiles SB; Kammesheidt A; Turek PJ
    Hum Reprod; 2004 Mar; 19(3):540-6. PubMed ID: 14998948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted extended cystic fibrosis mutation testing on known and at-risk patients and relatives.
    Lebo RV; Omlor GJ
    Genet Test; 2007; 11(4):427-44. PubMed ID: 18294061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation for clinical use of, and initial clinical experience with, a novel approach to population-based carrier screening using high-throughput, next-generation DNA sequencing.
    Hallam S; Nelson H; Greger V; Perreault-Micale C; Davie J; Faulkner N; Neitzel D; Casey K; Umbarger MA; Chennagiri N; Kramer AC; Porreca GJ; Kennedy CJ
    J Mol Diagn; 2014 Mar; 16(2):180-9. PubMed ID: 24374108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic testing and quality control in diagnostic laboratories.
    Dequeker E; Cassiman JJ
    Nat Genet; 2000 Jul; 25(3):259-60. PubMed ID: 10888869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic testing for cystic fibrosis: laboratory performance on the College of American Pathologists external proficiency surveys.
    Lyon E; Schrijver I; Weck KE; Ferreira-Gonzalez A; Richards CS; Palomaki GE;
    Genet Med; 2015 Mar; 17(3):219-25. PubMed ID: 25077647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactive trypsin/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels?
    Scotet V; Audrézet MP; Roussey M; Rault G; Dirou-Prigent A; Journel H; Moisan-Petit V; Storni V; Férec C
    Pediatrics; 2006 Nov; 118(5):e1523-9. PubMed ID: 17015492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosensor technology for real-time detection of the cystic fibrosis W1282X mutation in CFTR.
    Feriotto G; Ferlini A; Ravani A; Calzolari E; Mischiati C; Bianchi N; Gambari R
    Hum Mutat; 2001; 18(1):70-81. PubMed ID: 11438995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased frequency of cystic fibrosis transmembrane conductance regulator gene mutations in infertile males.
    Schulz S; Jakubiczka S; Kropf S; Nickel I; Muschke P; Kleinstein J
    Fertil Steril; 2006 Jan; 85(1):135-8. PubMed ID: 16412743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a BeadXpress assay for a 151-mutation and variant CFTR screening panel after 11,000 samples: implications for practice.
    Stoerker J; Goodman TG; Walline HM; Sugalski J; Holland CA
    Diagn Mol Pathol; 2013 Sep; 22(3):144-8. PubMed ID: 23846440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of five technologically diverse CFTR testing platforms.
    Johnson MA; Yoshitomi MJ; Richards CS
    J Mol Diagn; 2007 Jul; 9(3):401-7. PubMed ID: 17591940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DHPLC screening of cystic fibrosis gene mutations.
    Ravnik-Glavac M; Atkinson A; Glavac D; Dean M
    Hum Mutat; 2002 Apr; 19(4):374-83. PubMed ID: 11933191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.